Postoperative analgesia by infusion of local anesthetic into the surgical wound after modified radical mastectomy: a randomized clinical trial.

Plast Reconstr Surg

Vitoria-Gasteiz, Zaragoza, and Logroño, Spain From the Department of Anesthesiology and Postoperative Care, Araba Research Unit, and Department of Pharmacy, Araba University Hospital; the Department of Surgery, Zaragoza University Hospital; and the Department of Economics and Business, University La Rioja.

Published: December 2014

Background: There is no consensus on the efficacy of postoperative infusion of local anesthetics after radical mastectomy.

Methods: A randomized, double-blind, placebo-controlled, parallel-groups clinical trial was conducted in a tertiary hospital. Eighty consecutive women with operable breast cancer with indications for modified radical mastectomy without breast reconstruction were assigned randomly to receive infusion of levobupivacaine (0.5%) or saline at 2 ml/hour for 48 hours through a wound catheter. Seventy-three women finished the study (intervention group, n = 34; control group, n = 39). During surgery, all patients received 0.25% levobupivacaine (30 ml).

Results: The levobupivacaine group reported less pain (p < 0.001) than controls in the postanesthesia care unit (1.6 ± 1.3 versus 6.7 ± 1.8) and on the ward at 24 (0.8 ± 0.9 versus 4.2 ± 1.9) and 48 (0.4 ± 0.7 versus 3.3 ± 2.3) hours. In the postanesthesia care unit, the levobupivacaine group consumed less metamizole (0.4 ± 0.5 versus 0.8 ± 0.4; p < 0.001) and dexketoprofen (0.1 ± 0.3 versus 0.7 ± 0.4; p < 0.001), with differences in paracetamol use being insignificant (0.8 ± 0.4 versus 0.9 ± 0.3; p = 0.140). On the ward, the levobupivacaine group used significantly less paracetamol (0.5 ± 0.7 versus 2.0 ± 2.0; p < 0.001) and metamizole (0.2 ± 0.4 versus 1.2 ± 1.4; p < 0.001), but differences in dexketoprofen were not significant (0.03 ± 0.2 versus 0.2 ± 0.6; p = 0.074). In the postanesthesia care unit, the levobupivacaine and control groups consumed 0 ± 0 and 0.7 ± 1.2 doses of opioids (p = 0.001), respectively. The authors observed no differences in nausea and vomiting at any stage in the postanesthesia care unit (0.2 ± 0.4 versus 0.4 ± 0.5; p = 0.081) or on the ward (0.3 ± 0.5 versus 0.4 ± 0.5; p = 0.563). All participants reported high levels of satisfaction.

Conclusion: Continuous infusion of local anesthetic reduces pain and analgesic consumption, with high satisfaction, but does not affect rates of nausea and vomiting.

Download full-text PDF

Source
http://dx.doi.org/10.1097/PRS.0000000000000762DOI Listing

Publication Analysis

Top Keywords

postanesthesia care
16
care unit
16
versus 0001
16
infusion local
12
levobupivacaine group
12
versus
11
local anesthetic
8
modified radical
8
radical mastectomy
8
clinical trial
8

Similar Publications

Introduction: Supracondylar fractures are among the most common injuries in the pediatric population. Recently, there has been increased interest in developing opioid-free anesthetic protocols that achieve these same goals without the risks associated with opioid use, such as postoperative nausea and vomiting (PONV), delayed discharges, and respiratory depression.

Methods: Seattle Children's Hospital implemented opioid-free anesthesia (OFA) for pediatric supracondylar fracture repairs in January 2021.

View Article and Find Full Text PDF

Purpose: To analyze available evidence in the literature on the effect of aromatherapy for the management of postoperative pain in the postanesthesia care unit (PACU).

Design: Systematic review according to the Joanna Briggs Institute (JBI) model and Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement.

Methods: The search was carried out in August 2023, using descriptors and keywords, in the Cumulative Index to Nursing and Allied Health Literature, Latin American and Caribbean Literature in Health Sciences, Cochrane Central Register of Controlled Trials, Excerpta Medica Database, PUBMED, Scopus, Virtual Health Library, Google Scholar, CAPES, BDTD, and ProQuest portals of theses and dissertations, with no language restrictions or time limit.

View Article and Find Full Text PDF

Purpose: The purpose of the project was to reduce the occurrence of nonclinical delays resulting in increased postanesthesia care unit length of stay for carpal tunnel release patients in an ambulatory orthopedic surgery center through the implementation of new workflow processes in both the preoperative and postoperative phases of care.

Design: Pre-post design, with data being analyzed both before and after implementation of evidence-based quality improvement measures to assess for effectiveness of project interventions.

Methods: At the ambulatory orthopedic surgery center, preintervention data were gathered for 6 months on carpal tunnel release patients (n = 185) to determine the root causes of discharge delays (January to June 2023).

View Article and Find Full Text PDF

: In 2021, the Food and Drug Administration approved liposomal bupivacaine injectable suspension for single-dose infiltration in patients ≥ 6 years of age. Liposomal bupivacaine and bupivacaine hydrochloride admixtures may also be administered off-label for pediatric regional anesthesia including peripheral nerve blocks (PNBs). This single-injection, long-acting technique is not well described in pediatrics but may have benefits over traditional continuous catheter-based systems.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!